Anbio Biotechnology (NNNN) Earnings Analysis
Anbio Biotechnology (NNNN) has no confirmed upcoming earnings date. Trailing P/E 48.86.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does NNNN next report earnings?
No confirmed upcoming earnings date is currently scheduled for NNNN. This page updates as the calendar is published.
NNNN earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-07 | 0.0692 USD | n/a | n/a | n/a |
NNNN valuation and analyst view
| Trailing P/E | 48.86 |
|---|---|
| Trailing EPS | 0.19342 USD |
| Price / book | 13.75 |
| Dividend yield | 0.00% |
| Market cap | 0.41B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Anbio Biotechnology (NNNN)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for NNNN. This page updates as the calendar is published.
Did NNNN beat earnings last quarter?
Consensus estimate data was not available for NNNN's 2026-04-07 report.
What is NNNN's current P/E ratio and EPS?
NNNN trades at a trailing P/E of 48.86 on trailing EPS of 0.19342212106299211 USD.
What do analysts rate NNNN?
NNNN has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.